MedPath

Effect of shweta punarnava arka in dry eye syndrome

Phase 4
Conditions
Health Condition 1: H578- Other specified disorders of eye and adnexa
Registration Number
CTRI/2024/03/064589
Lead Sponsor
Dr Sudharani Gudaganatti
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients fulfilling the diagnostic criteria of Dry Eye Syndrome like Schimer s Test & Tear break-up time

Irrespective of occupation religion will be included

Exclusion Criteria

Severe conditions of ocular surface disorders

Severe conditions like Steven Johnsons syndrome Chemical Thermal Radiation burns idiopathic atrophy Trachoma Ocular pemphigoid Sjogrens Syndrome

Corneal epitheliopathies like Neuroparalytic keratitis post herpetic post measles infection of cornea etc

Conjunctival epitheliopathies like Pterygium Pseudo pterygium Tumors Retention cysts chronic low grade bacterial viral conjunctivitis

Lid abnormalities like Meibomitis Blepharitis Facial nerve palsy Lagophthalmos

Lacrimal gland diseases like infiltration of gland with sarcoidosis lymphoma leukemia and amyloidosis congenital Alacrima

Vitamin A deficiency effect of the drugs like atropine antihistamine diuretics

Specific systemic infections like Tuberculosis Leprosy Hypertension RA Diabetes mellitus etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the effect of Shweta Punarnava Arka Eyedrop on specific layer of tear filmTimepoint: Timeline of 45 days
Secondary Outcome Measures
NameTimeMethod
To study the effect of Carboxy methyl cellulose 0.5% on specific layer of tear filmTimepoint: Timeline of 45 days
© Copyright 2025. All Rights Reserved by MedPath